01Equipment
Which device?
Manufacturer, intended use, control mechanism, needle cartridge and maintenance are identified.
Medical Microneedling · Scalp Assessment · Istanbul
Medical Microneedling · Scalp Assessment · Istanbul
Medical Microneedling
Medical microneedling is a procedure performed with a specific device and sterile needle cartridge; it is not identified by the word needling alone. Device design, needle geometry, movement, target tissue, scalp condition and any accompanying product must be assessed separately.
Scalp microneedling is not RF microneedling and does not automatically authorise drug, cosmetic, PRP or exosome delivery. No personal needle depth or home protocol is provided online.
Quick Orientation
Four questions before scalp needling
The procedure is defined by device, tissue and purpose.
A safe discussion separates the instrument, the mechanical injury, the target layer and any substance placed on or into the treated area.
02Tissue
Which scalp condition?
Diagnosis, barrier, inflammation, infection, scarring and pigmentation tendency are examined.
03Indication
What is the clinical aim?
A defined hair or scalp question is linked to an objective endpoint rather than general stimulation.
04Combination
Is anything added?
Topical medicine, cosmetic or biological material is evaluated as a separate exposure.
Procedure Identity
Device · puncture · tissue response
Medical microneedling is a controlled injury, not a generic beauty step.
Sterile needles create microscopic punctures in a selected tissue plane. The biological response and risk depend on the device, technique, tissue and accompanying care.
What it can provide
- Create a documented mechanical scalp procedure using a specified device
- Be considered as an adjunct for a diagnosed hair-loss question
- Separate sterile needling from any accompanying product
- Link tolerability and a hair endpoint to planned follow-up
What it cannot establish
- Diagnose hair loss from the procedure name
- Turn an unapproved product combination into an authorised use
- Be treated as equivalent to RF microneedling or mesotherapy
- Guarantee growth, density, absorption or a fixed session number
Creating channels can change product penetration and risk. Needling and any applied or injected substance therefore require separate clinical and regulatory review.
Medical Suitability
Scalp diagnosis before device settings
Five checks determine whether needling is reasonable.
Photographs may show distribution but cannot examine barrier integrity, active inflammation, infection, scarring tendency or the intended tissue plane.
- 01
Diagnose the hair loss
Pattern loss is separated from inflammatory, scarring, autoimmune, infectious and sudden loss.
- 02
Examine scalp and hair
Barrier, lesions, active disease, hair shafts, pigment tendency and previous scars are assessed.
- 03
Review healing and bleeding
Medicines, anticoagulation, immune status, diabetes, keloid history and healing factors are discussed.
- 04
Verify device and hygiene
Intended use, cartridge integrity, single-use status, cleaning and cross-contamination controls are checked.
- 05
Define endpoint and alternative
Established medical treatment, observation or another procedure may have priority.
Device and Procedure
Sterility · controlled injury · aftercare
The safety chain begins before the cartridge touches the scalp.
A documented procedure covers device identity, sterile preparation, clinical endpoint, infection control and post-procedure review without publishing personal settings.
01Preparation
Confirm tissue and equipment
The scalp is examined and the device, cartridge, intended use and sterile field are checked.
- Exclude active infection or inflammation
- Verify cartridge and device integrity
- Record baseline and clinical purpose
02Procedure
Control the mechanical exposure
A clinician selects settings and technique for the examined tissue while monitoring bleeding and tolerance.
- Keep device and target plane documented
- Avoid unreviewed product combinations
- Record treated area and immediate response
03Recovery
Protect barrier and observe
Aftercare supports the disrupted barrier and separates expected redness from infection, pigment or scar concerns.
- Use a simple product-specific care plan
- Define contact and review points
- Delay further exposure until healing is assessed
Published research settings or manufacturer ranges are not copied into a personal protocol. The examined scalp and exact device determine clinical decisions.
Evidence and Limits
Adjunct studies · variable devices and methods
A study signal does not define one universal technique.
Randomised and comparative studies have explored microneedling, often with topical minoxidil, in androgenetic alopecia. Devices, techniques, comparators and follow-up vary.
Adjunct evidence is specific
A combination study cannot show the independent effect of needling or apply to another medicine.
Device details matter
Rollers, powered pens, needle geometry and procedural endpoints are not interchangeable.
Diagnosis remains narrow
Pattern-hair-loss data do not justify needling active scarring, inflammatory or infectious disease.
Long-term questions remain
Maintenance, ideal intervals and comparative benefit are not established as a single standard.
Evidence does not support a guaranteed response, a home depth, a universal combination or an automatic treatment series.
Individual Plan
Diagnosis and healing define each step
The plan is a monitored procedure, not a depth recipe.
The indication, device, tissue findings, other treatments, recovery and endpoint determine whether any needling step is justified.
Secure the baseline
Diagnosis, scalp examination, photographs, endpoint, medicines and previous procedures are recorded.
Specify the device
Equipment, cartridge, sterile controls and clinical purpose remain traceable.
Limit the first procedure
The treated region and recovery review are defined without promising a course length.
Reassess before repeating
Healing, adverse effects, objective findings and alternatives determine the next decision.
Course and Follow-Up
Barrier recovery · pigment and scar surveillance
Healing is assessed before any hair endpoint.
Immediate puncture effects, barrier recovery and the slower hair cycle are documented on different timelines.
- 01Procedure
Immediately
Redness, pinpoint bleeding, tenderness, warmth or swelling may follow the mechanical procedure.
- 02Barrier
Early healing
Increasing pain, discharge, persistent inflammation or delayed recovery needs clinical review.
- 03Tissue
Later skin review
Post-inflammatory pigment change, prolonged redness or scar alteration is assessed.
- 04Endpoint
Hair review
Comparable photographs and the pre-agreed measure are evaluated after an appropriate observation period.
Risks and Alternatives
Infection, pigmentation and scarring
A small needle can still create clinically important injury.
Risk includes pain, bleeding, infection, reactivation of skin conditions, pigment change, prolonged inflammation, scarring and unexpected product exposure.
01Tissue
Barrier and infection
Cross-contamination, active scalp disease or poor aftercare can increase infection and inflammation risk.
02Healing
Pigment and scar
Post-inflammatory hyperpigmentation, hypopigmentation or scar change may occur in susceptible skin.
03Alternative
Other strategy
Diagnosis-led medication, observation, non-needling support or transplantation planning may be more appropriate.
04Decision
Withhold or stop
Treatment is withheld or stopped when the indication, consent, safety controls or follow-up cannot support a proportionate plan.
RF microneedling has a different energy-related risk profile and is not represented by this mechanical scalp-needling page.
Istanbul and Follow-Up
Allow time for barrier recovery
Travel plans must account for healing and later review.
The clinical assessment, procedure day, early scalp care and an objective hair endpoint are planned as one pathway.
01Before travel
Prepare the history
Hair-loss course, scalp symptoms, medicines, bleeding risk and previous procedures are organised.
02In Istanbul
Examine in person
Diagnosis, tissue, device, combination risks, alternatives and aftercare are reviewed.
03Treatment day
Protect recovery
Any procedure would record device, cartridge, region and immediate response before discharge.
04After return
Review consistently
Healing concerns and later hair measures use an agreed contact route and image standard.
The Doctor Aslan Approach
Device and tissue before technique
No depth is prescribed without examining the scalp.
The device, sterile cartridge, tissue target and any accompanying product are kept separate. The procedure remains subordinate to diagnosis and follow-up.
Identify the instrument
A named device and cartridge replace generic needling language.
Examine the barrier
Inflammation, infection, pigment and scar risk guide suitability.
Separate combinations
A topical or biological product needs its own evidence and safety review.
Wait for healing
Another procedure is not considered until tissue recovery has been assessed.
Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information about medical microneedling of the scalp; no personal diagnosis, protocol or outcome guarantee
Frequently Asked Questions
Short and clear
Questions commonly asked before a decision.
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
01What is Medical Microneedling?+
Medical Microneedling is described on this page as one defined clinical route. Its role, limits and possible alternatives are considered together rather than treating the method name as a personal recommendation.
02Who may be assessed for Medical Microneedling?+
Suitability depends on the medical question, history, examination, the exact product or device where relevant, realistic aims and an individual benefit–risk assessment.
03What remains undecided after an online review?+
Diagnosis, definitive suitability, the treatment protocol, product, dose or device settings, expected response and the option not to proceed remain subject to personal medical assessment.
04How are treatment and follow-up in Istanbul planned?+
The in-person examination remains the decision point. Expected early reactions, warning signs, the direct contact route, return travel and access to appropriate local medical care are discussed before treatment.
Next Step
Diagnose the scalp · identify the device